Kay Elston
Wellcome/MRC Cambridge Stem Cell Institute(GB)University of Cambridge(GB)Clinical Trial Investigators(US)
Research Areas
COVID-19 Clinical Research Studies, interferon and immune responses, SARS-CoV-2 and COVID-19 Research, Anesthesia and Sedative Agents, Intensive Care Unit Cognitive Disorders
Most-Cited Works
- → Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study(2025)3 cited
- → The DIRECT study: A roadmap for ctDNA-based risk prediction, molecular profiling and MRD detection in Diffuse Large B Cell Lymphoma(2025)1 cited